Oracle and NIH Collaborate on Cloud System to Support COVID-19 Trials

The National Institute of Allergy and Infectious Diseases has recently established the COVID-19 Prevention Network (CoVPN), with a goal to register millions of volunteers for large-scale clinical testing of vaccines and monoclonal antibodies intended to protect people from COVID-19. As part of this initiative, Oracle has developed a Cloud System called the CoVPN Volunteer Screening Registry to identify and screen volunteers who want to participate in COVID-19 clinical trials.

 

For more information, click here.